Latest Insider Transactions at Bio Atla, Inc. (BCAB)
This section provides a real-time view of insider transactions for Bio Atla, Inc. (BCAB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BioAtla, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BioAtla, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 31
2024
|
Eric Sievers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
572
-0.27%
|
$572
$1.77 P/Share
|
|
Aug 31
2024
|
Scott Andrew Smith |
SELL
Payment of exercise price or tax liability
|
Direct |
2,181
-0.73%
|
$2,181
$1.77 P/Share
|
|
Jul 31
2024
|
Scott Andrew Smith |
SELL
Payment of exercise price or tax liability
|
Direct |
2,181
-0.72%
|
$2,181
$1.81 P/Share
|
|
Jul 31
2024
|
Eric Sievers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
572
-0.27%
|
$572
$1.81 P/Share
|
|
Jun 30
2024
|
Scott Andrew Smith |
SELL
Payment of exercise price or tax liability
|
Direct |
2,181
-0.72%
|
$2,181
$1.37 P/Share
|
|
Jun 30
2024
|
Eric Sievers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
572
-0.27%
|
$572
$1.37 P/Share
|
|
Jun 13
2024
|
Lawrence Steinman |
BUY
Grant, award, or other acquisition
|
Direct |
16,500
+23.09%
|
-
|
|
Jun 13
2024
|
Scott Andrew Smith |
BUY
Grant, award, or other acquisition
|
Direct |
16,500
+5.14%
|
-
|
|
Jun 13
2024
|
Sylvia Mcbrinn |
BUY
Grant, award, or other acquisition
|
Direct |
16,500
+31.65%
|
-
|
|
Jun 13
2024
|
Mary Ann Gray |
BUY
Grant, award, or other acquisition
|
Direct |
16,500
+23.44%
|
-
|
|
Jun 13
2024
|
Susan Moran |
BUY
Grant, award, or other acquisition
|
Direct |
16,500
+36.42%
|
-
|
|
Jun 13
2024
|
Eddie Williams |
BUY
Grant, award, or other acquisition
|
Direct |
16,500
+31.02%
|
-
|
|
May 31
2024
|
Scott Andrew Smith |
SELL
Payment of exercise price or tax liability
|
Direct |
2,181
-0.75%
|
$2,181
$1.51 P/Share
|
|
May 31
2024
|
Eric Sievers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
572
-0.27%
|
$572
$1.51 P/Share
|
|
Apr 30
2024
|
Scott Andrew Smith |
SELL
Payment of exercise price or tax liability
|
Direct |
2,181
-0.75%
|
$4,362
$2.26 P/Share
|
|
Apr 30
2024
|
Eric Sievers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
572
-0.27%
|
$1,144
$2.26 P/Share
|
|
Mar 31
2024
|
Eric Sievers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
572
-0.27%
|
$1,716
$3.44 P/Share
|
|
Mar 31
2024
|
Scott Andrew Smith |
SELL
Payment of exercise price or tax liability
|
Direct |
2,181
-0.74%
|
$6,543
$3.44 P/Share
|
|
Feb 29
2024
|
Scott Andrew Smith |
SELL
Payment of exercise price or tax liability
|
Direct |
2,181
-0.73%
|
$4,362
$2.7 P/Share
|
|
Feb 29
2024
|
Eric Sievers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
572
-0.27%
|
$1,144
$2.7 P/Share
|
|
Feb 16
2024
|
Jay M Phd Short Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
417,000
+18.34%
|
-
|
|
Feb 15
2024
|
Eric Sievers Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
122,000
+36.57%
|
-
|
|
Feb 15
2024
|
Richard A Waldron Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
106,000
+31.46%
|
-
|
|
Feb 15
2024
|
Christian Vasquez Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,000
+27.38%
|
-
|
|
Jan 31
2024
|
Eric Sievers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
657
-0.73%
|
$657
$1.92 P/Share
|
|
Jan 31
2024
|
Scott Andrew Smith |
SELL
Payment of exercise price or tax liability
|
Direct |
2,181
-0.73%
|
$2,181
$1.92 P/Share
|
|
Dec 31
2023
|
Eddie Williams |
BUY
Grant, award, or other acquisition
|
Direct |
4,827
+19.29%
|
-
|
|
Dec 31
2023
|
Eric Sievers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
555
-0.61%
|
$1,110
$2.46 P/Share
|
|
Dec 31
2023
|
Scott Andrew Smith |
SELL
Payment of exercise price or tax liability
|
Direct |
1,791
-0.6%
|
$3,582
$2.46 P/Share
|
|
Dec 31
2023
|
Mary Ann Gray |
BUY
Grant, award, or other acquisition
|
Direct |
5,995
+13.82%
|
-
|
|
Dec 26
2023
|
Sylvia Mcbrinn |
BUY
Open market or private purchase
|
Direct |
4,000
+20.92%
|
$8,000
$2.33 P/Share
|
|
Dec 20
2023
|
Jay M Phd Short Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
50,000
+3.36%
|
$100,000
$2.14 P/Share
|
|
Dec 19
2023
|
Lawrence Steinman |
BUY
Open market or private purchase
|
Direct |
20,000
+34.21%
|
$40,000
$2.05 P/Share
|
|
Dec 19
2023
|
Christian Vasquez Officer |
BUY
Open market or private purchase
|
Direct |
7,495
+6.09%
|
$14,990
$2.04 P/Share
|
|
Nov 30
2023
|
Eric Sievers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
554
-0.61%
|
$554
$1.77 P/Share
|
|
Nov 30
2023
|
Scott Andrew Smith |
SELL
Payment of exercise price or tax liability
|
Direct |
1,791
-0.59%
|
$1,791
$1.77 P/Share
|
|
Oct 31
2023
|
Richard A Waldron Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
970
-0.77%
|
$970
$1.47 P/Share
|
|
Oct 31
2023
|
Jay M Phd Short Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,888
-0.21%
|
$2,888
$1.47 P/Share
|
|
Oct 31
2023
|
Christian Vasquez Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
194
-0.19%
|
$194
$1.47 P/Share
|
|
Oct 31
2023
|
Scott Andrew Smith |
SELL
Payment of exercise price or tax liability
|
Direct |
1,791
-0.59%
|
$1,791
$1.47 P/Share
|
|
Oct 31
2023
|
Eric Sievers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
555
-0.6%
|
$555
$1.47 P/Share
|
|
Sep 30
2023
|
Mary Ann Gray |
BUY
Grant, award, or other acquisition
|
Direct |
8,676
+21.65%
|
-
|
|
Sep 30
2023
|
Eddie Williams |
BUY
Grant, award, or other acquisition
|
Direct |
6,985
+31.24%
|
-
|
|
Sep 30
2023
|
Christian Vasquez Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
194
-0.19%
|
$194
$1.7 P/Share
|
|
Sep 30
2023
|
Richard A Waldron Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
970
-0.76%
|
$970
$1.7 P/Share
|
|
Sep 30
2023
|
Jay M Phd Short Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,888
-0.21%
|
$2,888
$1.7 P/Share
|
|
Sep 30
2023
|
Eric Sievers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
554
-0.6%
|
$554
$1.7 P/Share
|
|
Sep 30
2023
|
Scott Andrew Smith |
SELL
Payment of exercise price or tax liability
|
Direct |
1,791
-0.59%
|
$1,791
$1.7 P/Share
|
|
Sep 08
2023
|
Sylvia Mcbrinn |
BUY
Open market or private purchase
|
Direct |
2,000
+15.24%
|
$4,000
$2.54 P/Share
|
|
Aug 31
2023
|
Christian Vasquez Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
194
-0.19%
|
$388
$2.51 P/Share
|